Biomedical Advanced Research and Development Authority (BARDA)

Total investments

58

Average round size

41M

Portfolio companies

43

Rounds per year

3.22

Lead investments

14

Follow on index

0.26

Exits

20

Areas of investment
BiotechnologyHealth CareHealth DiagnosticsGeneticsManufacturingMedical DeviceMedicalPharmaceuticalTherapeuticsBiopharma

Investments analytics

Analytics

Total investments
58
Lead investments
14
Exits
20
Rounds per year
3.22
Follow on index
0.26
Investments by industry
  • Biotechnology (40)
  • Health Care (39)
  • Medical (22)
  • Medical Device (15)
  • Pharmaceutical (11)
  • Show 28 more
Investments by region
  • United States (49)
  • Italy (1)
  • France (1)
  • Australia (1)
  • United Kingdom (2)
  • Show 4 more
Peak activity year
2020
Number of Unicorns
4
Number of Decacorns
4
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
29
Avg. valuation at time of investment
452M
Group Appearance index
0.05
Avg. company exit year
16
Avg. multiplicator
4.97
Strategy success index
1.00

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
26 Aug 2014 Software, FinTech, Banking Venture - Series Unknown 10M United States, New Haven
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.